RCM:NSD-R1 RCM Inc (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 14.26

Change

+0.01 (+0.07)%

Market Cap

USD 6.02B

Volume

0.78M

Analyst Target

USD 17.88
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

R1 RCM Inc. provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers. The company also offers modular solutions, including functional partnership, an outsourcing solutions for improvements across targeted revenue cycle areas for hospital and physician group customers; revenue recovery, to fast-track payer and patient cash collections; revenue optimization, a solution to uncover missed or underreported revenue; clinical integrity, used to improve documentation and coding accuracy to maximize earned revenue for the services provided; and regulatory navigation, a compliance-first solutions for government reimbursement accuracy, pharmacy savings, and compliance. R1 RCM Inc. was formerly known as Accretive Health, Inc. and changed its name to R1 RCM Inc. in January 2017. The company was incorporated in 2003 and is headquartered in Murray, Utah.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-30 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
GEHC GE HealthCare Technologies Inc..

+1.93 (+2.26%)

USD 41.71B
TEM Tempus AI, Inc. Class A Common..

+0.29 (+0.64%)

USD 7.92B
HQY HealthEquity Inc

-0.90 (-1.03%)

USD 7.65B
WAY Waystar Holding Corp. Common S..

+0.46 (+1.64%)

USD 4.47B
BTSG BrightSpring Health Services, ..

-0.95 (-5.97%)

USD 2.71B
GDRX Goodrx Holdings Inc

-0.03 (-0.47%)

USD 2.62B
PRVA Privia Health Group Inc

+0.76 (+4.23%)

USD 2.09B
PINC Premier Inc

+0.12 (+0.60%)

USD 2.00B
OMCL Omnicell Inc

+12.93 (+32.23%)

USD 1.84B
CERT Certara Inc

-0.04 (-0.39%)

USD 1.84B

ETFs Containing RCM

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 34.91% 70% C- 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 34.91% 70% C- 73% C
Trailing 12 Months  
Capital Gain 17.85% 63% D 52% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.85% 63% D 53% F
Trailing 5 Years  
Capital Gain 31.91% 81% B- 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 31.91% 81% B- 64% D
Average Annual (5 Year Horizon)  
Capital Gain 10.93% 76% C+ 65% D
Dividend Return 10.93% 74% C 62% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 56.05% 40% F 34% F
Risk Adjusted Return 19.50% 73% C 53% F
Market Capitalization 6.02B 94% A 89% A-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.